New hope for tough cancers: experimental drug enters first human tests
NCT ID NCT07459283
Summary
This is a very early study to find the safest dose of a new drug called 177Lu-INN805 for people with advanced solid tumors that haven't responded to standard treatments. It will enroll about 10 patients with cancers like head & neck, lung, breast, or sarcoma to test how the body handles the drug and look for any side effects. The main goal is to determine how much medicine can be given safely, not to prove it cures cancer at this stage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, China
Contact
Conditions
Explore the condition pages connected to this study.